Podcast: Regulus Therapeutics and Outsourcing Strategies - - BioPharm International

ADVERTISEMENT

Podcast: Regulus Therapeutics and Outsourcing Strategies


blog comments powered by Disqus


Focusing on outsourcing strategies, BioPharm International interviews for a second time Bal Bhat, senior director and head of chemistry at Regulus, a company that develops and manufactures oligonucleotides to support the discovery and development of microRNA therapeutics. Bhat discusses the reasoning behind Regulus’ choice of outsourcing partners and how working closely with those partners to harmonize methodology and data quality is crucial. Bhat also describes how engaging outsourcing partners with the excitement of microRNA technology enabled an improved working relationship with shared goals. Posted Nov. 2011.

Related article on Perspectives in MicroRNA Therapeutics

Podcast: Dr. Bhat focuses on microRNA Drug Delivery

ADVERTISEMENT

ADVERTISEMENT

Compounding Pharmacy Issues Recall, But Challenges FDA Decision
July 22, 2014
AbbVie's Acquisition of Shire Could Save $8 Billion in Taxes
July 21, 2014
AbbVie to Acquire Shire for $54.7 Billion
July 18, 2014
AstraZeneca Reveals Design for New Global R&D Center and Corporate Headquarters
July 18, 2014
Particulate Matter Prompts Baxter's Recall of IV Solutions
July 17, 2014
Author Guidelines

Click here